Ye Chen
Guangzhou University of Chinese Medicine(CN)
Publications by Year
Research Areas
Gut microbiota and health, Helicobacter pylori-related gastroenterology studies, Gastric Cancer Management and Outcomes, Inflammatory Bowel Disease, Clostridium difficile and Clostridium perfringens research
Most-Cited Works
- → Fifth Chinese National Consensus Report on the management ofHelicobacter pyloriinfection(2018)428 cited
- → Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)(2021)341 cited
- → Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction(2018)313 cited
- → Alteration of the gut microbiota in Chinese population with chronic kidney disease(2017)267 cited
- → Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the macrophage/WNT/ERK signaling pathway(2022)233 cited
- → Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy(2019)193 cited
- → 2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment(2022)192 cited
- → Chinese Consensus Report on Family-BasedHelicobacter pyloriInfection Control and Management (2021 Edition)(2021)180 cited
- → Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway(2021)161 cited
- → Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease(2022)161 cited